Organon & Co | OGN - Trade Creditors


Organon & Co reported $983M in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
Bristol-Myers Squibb USD 4.23B 659M Mar/2026
Celltrion KRW 88.58B 9.9B Mar/2026
Cspc Pharmaceutical CNY 2.32B 236.83M Dec/2025
Deva Holding AS TRY 809.81M 105.88M Sep/2023
Dianthus Therapeutics USD 5.27M 4.45M Mar/2026
Divis Laboratories Ltd INR 12.11B 1.71B Mar/2026
Gilead Sciences USD 645M 70M Mar/2026
Glaxosmithkline GBP 14.34B 6.39B Mar/2026
Kangmei Pharma CNY 2.46B 153.5M Mar/2026
Knight Therapeutics CAD 125.76M 7.63M Dec/2025
Laboratorios Farma EUR 107.59M 341K Dec/2023
Malin Corporation EUR 700K 200K Dec/2024
Medical Developments International AUD 4.31M 2.18M Dec/2025
Merck USD 3.86B 541M Mar/2026
Neuren Pharmaceuticals AUD 2.4M 4.26M Dec/2025
Novartis USD 4.32B 134M Mar/2026
Organigram Holdings CAD 73.14M 2.06M Mar/2026
Organon & Co USD 983M 31M Mar/2026
Ovoca Bio EUR 186K 23K Jun/2025
Pharma Mar EUR 43.83M 10.51M Mar/2026
Qiagen NV USD 72.66M 2.11M Dec/2025
Sartorius EUR 345.3M 2.2M Mar/2026
Sino Biopharmaceutical CNY 2.82B 1.32B Jun/2025
Tilray USD 114.5M 3.69M Sep/2025
Zealand Pharma A/S 346.6M 102.71M Dec/2025